These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3966244)

  • 1. Absence of a promoting or sequential syncarcinogenic effect in rat liver by the carcinogenic hypolipidemic drug nafenopin given after N-2-fluorenylacetamide.
    Numoto S; Mori H; Furuya K; Levine WG; Williams GM
    Toxicol Appl Pharmacol; 1985 Jan; 77(1):76-85. PubMed ID: 3966244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the hepatocarcinogenic peroxisome-proliferating hypolipidemic agents clofibrate and nafenopin on the rat liver cell membrane enzymes gamma-glutamyltranspeptidase and alkaline phosphatase and on the early stages of liver carcinogenesis.
    Numoto S; Furukawa K; Furuya K; Williams GM
    Carcinogenesis; 1984 Dec; 5(12):1603-11. PubMed ID: 6149819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinction between liver neoplasm promoting and syncarcinogenic effects demonstrated by exposure to phenobarbital or diethylnitrosamine either before or after N-2-fluorenylacetamide.
    Williams GM; Furuya K
    Carcinogenesis; 1984 Feb; 5(2):171-4. PubMed ID: 6697434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the hepatocarcinogen nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital.
    Furukawa K; Numoto S; Furuya K; Furukawa NT; Williams GM
    Cancer Res; 1985 Oct; 45(10):5011-9. PubMed ID: 2862989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the biological effects of phenobarbital and nafenopin on rat hepatocarcinogenesis.
    Préat V; Lans M; de Gerlache J; Taper H; Roberfroid M
    Jpn J Cancer Res; 1986 Jul; 77(7):629-38. PubMed ID: 2875050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of rapid initiating, promoting or sequential syncarcinogenic effects of di(2-ethylhexyl)phthalate in rat liver carcinogenesis.
    Williams GM; Maruyama H; Tanaka T
    Carcinogenesis; 1987 Jul; 8(7):875-80. PubMed ID: 3594721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoplastic conversion in rat liver by the antihistamine methapyrilene demonstrated by a sequential syncarcinogenic effect with N-2-fluorenylacetamide.
    Furuya K; Williams GM
    Toxicol Appl Pharmacol; 1984 Jun; 74(1):63-9. PubMed ID: 6729822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of hepatocarcinogenesis by sequential administration of chemicals: summation versus promotion effects.
    Williams GM; Katayama S; Ohmori T
    Carcinogenesis; 1981; 2(11):1111-7. PubMed ID: 6119166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent reduction of N-2-fluorenylacetamide-induced liver cancer and enhancement of bladder cancer in rats by butylated hydroxytoluene.
    Maeura Y; Weisburger JH; Williams GM
    Cancer Res; 1984 Apr; 44(4):1604-10. PubMed ID: 6704970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl sulfotransferase IV deficiency in rat liver carcinogenesis initiated with diethylnitrosamine and promoted with N-2-fluorenylacetamide or its C-9-oxidized metabolites.
    Malejka-Giganti D; Ringer DP; Vijayaraghavan P; Kiehlbauch CC; Kong J
    Exp Mol Pathol; 1997 Apr; 64(2):63-77. PubMed ID: 9316585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of reserpine on N-2-fluorenylacetamide-induced hepatocarcinogenesis in rats.
    Sugie S; Tanaka T; Kuniyasu T; Mori H
    Toxicol Lett; 1987 Jul; 37(2):115-9. PubMed ID: 3603587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of the anorectic agent 1,3-bis[2-cyano-5-(trifluoromethyl)-phenyl]triazene in in vitro and in vivo liver promoting assays.
    Maruyama H; Tanaka T; Williams GM
    Cancer Lett; 1988 May; 40(1):13-21. PubMed ID: 3370626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of hyperplastic liver nodules in hepatectomized rats treated with 3'-methyl-4-dimethylaminoazobenzene, benzo[a]pyrene or phenobarbital before or after exposure to N-2-fluorenylacetamide.
    Hasegawa R; Tatematsu M; Tsuda H; Shirai T; Hagiwara A; Ito N
    Gan; 1982 Apr; 73(2):264-9. PubMed ID: 6288500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing effect of butylated hydroxytoluene on the development of liver altered foci and neoplasms induced by N-2-fluorenylacetamide in rats.
    Maeura Y; Williams GM
    Food Chem Toxicol; 1984 Mar; 22(3):191-8. PubMed ID: 6538537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An enhancing effect of the antihistaminic drug methapyrilene on rat liver carcinogenesis by previously administered N-2-fluorenylacetamide.
    Furuya K; Mori H; Williams GM
    Toxicol Appl Pharmacol; 1983 Aug; 70(1):49-56. PubMed ID: 6612738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver.
    Kraupp-Grasl B; Huber W; Putz B; Gerbracht U; Schulte-Hermann R
    Cancer Res; 1990 Jun; 50(12):3701-8. PubMed ID: 1971196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influences of different polychlorinated biphenyls on cytocidal, mitoinhibitory, and nodule-selecting activities of N-2-fluorenylacetamide in rat liver.
    Hayes MA; Roberts E; Safe SH; Farber E; Cameron RG
    J Natl Cancer Inst; 1986 Apr; 76(4):683-91. PubMed ID: 2870208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinomas in acatalasemic mice treated with nafenopin, a hypolipidemic peroxisome proliferator.
    Reddy JK; Rao S; Moody DE
    Cancer Res; 1976 Apr; 36(4):1211-7. PubMed ID: 177202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of polyprenoic acid (E-5166) on N-2-fluorenylacetamide-initiated hepatocarcinogenesis in rats.
    Shima H; Kuniyasu T; Sugie S; Tanaka T; Mori H; Takahashi M; Muto Y
    Jpn J Cancer Res; 1986 Apr; 77(4):351-5. PubMed ID: 3084425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of various chemicals on the development of hyperplastic liver nodules in hepatectomized rats treated with N-nitrosodiethylamine or N-2-fluorenylacetamide.
    Ito N; Tatematsu M; Nakanishi K; Hasegawa R; Takano T; Imaida K; Ogiso T
    Gan; 1980 Dec; 71(6):832-42. PubMed ID: 7274629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.